Journal of Virology · 2017 · 15 citations · 69 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsMolecular VirologyVaccinologyAntiviral ImmunityInterferon ResponsesLive Attenuated VaccinesViral InfectionsViral PathogenesisViral VaccinesAntiviral Innate SignalingAntiviral Interferon ResponsesHerpes Simplex Virus VaccinesInhibition Of Interferon ResponsesInterferon ProductionInterferon Response To Viral InfectionType I Interferon InductionType I Interferon Responses
ABSTRACT Viral fitness dictates virulence and capacity to evade host immune defenses. Understanding the biological underpinnings of such features is essential for rational vaccine development. We have previously shown that the live-attenuated herpes simplex virus 1 (HSV-1) mutant lacking the nuclear localization signal (NLS) on the ICP0 gene (0ΔNLS) is sensitive to inhibition by interferon beta (IFN-β) in vitro and functions as a highly efficacious experimental vaccine. Here, we characterize the host immune response and in vivo pathogenesis of HSV-1 0ΔNLS relative to its fully virulent parental strain in C57BL/6 mice. Additionally, we explore the role of type 1 interferon (IFN-α/β) signaling on virulence and immunogenicity of HSV-1 0ΔNLS and uncover a probable sex bias in the induction of IFN-α/β in the cornea during HSV-1 infection. Our data show that HSV-1 0ΔNLS lacks neurovirulence even in highly immunocompromised mice lacking the IFN-α/β receptor. These studies support the translational viability of the HSV-1 0ΔNLS vaccine strain by demonstrating that, while it is comparable to a virulent parental strain in terms of immunogenicity, HSV-1 0ΔNLS does not induce significant tissue pathology. IMPORTANCE HSV-1 is a common human pathogen associated with a variety of clinical presentations ranging in severity from periodic “cold sores” to lethal encephalitis. Despite the consistent failures of HSV subunit vaccines in clinical trials spanning the past 28 years, opposition to live-attenuated HSV vaccines predicated on unfounded safety concerns currently limits their widespread acceptance. Here, we demonstrate that a live-attenuated HSV-1 vaccine has great translational potential.
69
Vaccines: past, present and future
Stanley A. Plotkin · Nature Medicine · 2005 · 580 citations · Full text
An enteric virus can replace the beneficial function of commensal bacteria
Elisabeth Kernbauer, Yi Ding, Ken Cadwell · Nature · 2014 · 534 citations
Life Sciences, Biology, Microbiology +13